<?xml version="1.0" encoding="UTF-8"?>
<p>Both depletion of antioxidant defences or abnormal ROS production, result in the oxidative stress state that implicated in the aetiology of a variety of disorders such as Alzheimer’s
 <xref rid="CIT0003" ref-type="bibr">
  <sup>3</sup>
 </xref>, rheumatoid arthritis
 <xref rid="CIT0004" ref-type="bibr">
  <sup>4</sup>
 </xref>, Huntington’s disease
 <xref rid="CIT0005" ref-type="bibr">
  <sup>5</sup>
 </xref>, Parkinson’s disease
 <xref rid="CIT0006" ref-type="bibr">
  <sup>6</sup>
 </xref>, coronary heart disease
 <xref rid="CIT0007" ref-type="bibr">
  <sup>7</sup>
 </xref>, and insulin resistance
 <xref rid="CIT0008" ref-type="bibr">
  <sup>8</sup>
 </xref>. Furthermore, elevated levels of ROS can promote tumorigenesis by initiation of mitochondrial or nuclear DNA mutations that promote neoplastic transformation, promoting genomic instability, or activating pro-oncogenic signalling pathways
 <xref rid="CIT0009" ref-type="bibr">
  <sup>9</sup>
 </xref>. So, novel antioxidants featuring a variety of chemical structures are needed for prevention of cancer and to augment chemotherapies for different malignancies.
</p>
